Skip to main content English

Publikationen

 

Pubmed  Publikationsliste

Selected:

  1. Kyrle PA, et al. Inhibition of prostacyclin and thromboxane A2 generation by low dose aspirin at the site of plug formation in man in vivo. Circulation. 1987; 75: 1025-1029.
  2. Greengard J, Eichinger S, et al. Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg Gl mutation in the gene for factor V. N Engl J Med 331:1559-1562, 1994
  3. Eichinger S, et al. The risk of recurrent venous thromboembolism in patients without and with factor V Leiden. Thromb Haemost 1997; 77: 624-628   
  4. Furlan M, ..., Kyrle PA, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998; 339: 1578-1584
  5. Kyrle PA, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-462.
  6. Eichinger S et al. D-Dimer levels and risk of recurrent venous thromboembolism. JAMA 2003; 290:1071-74.
  7. Kyrle PA et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350: 2558-63
  8. Hron G, …, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006; 296: 397-402.
  9. Eichinger S et al. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: The Vienna prediction model. Circulation 2010; 121:1630-6. (editor’s pick)
  10.  Becattini C, …, Eichinger S, et al. for the WARFASA Investigators. Aspirin for prevention of recurrence of venous thromboembolism. N Engl J Med 366:1959-67, 2012
  11.  Kyrle PA et al. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J Thromb Haemost. 2016; 14:2402-09.
  12.  Traby L, … Kyrle PA. Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects. J Thromb Haemost. 2016; 14:273-81
  13.  Eichinger S et al.  Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease. J Thromb Haemost. 2018;16:31-35
  14.  Greinacher A, …., Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384(22):2092-2101.
  15.  Eichinger S. Reversing vitamin K antagonists: making the old new again. Hematology Am Soc Hematol Educ Program. 2016:605-611, 2016 (invited)